MX361944B - Methods for detecting signatures of disease or conditions in bodily fluids. - Google Patents
Methods for detecting signatures of disease or conditions in bodily fluids.Info
- Publication number
- MX361944B MX361944B MX2013000916A MX2013000916A MX361944B MX 361944 B MX361944 B MX 361944B MX 2013000916 A MX2013000916 A MX 2013000916A MX 2013000916 A MX2013000916 A MX 2013000916A MX 361944 B MX361944 B MX 361944B
- Authority
- MX
- Mexico
- Prior art keywords
- conditions
- methods
- disease
- bodily fluids
- detecting signatures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Abstract
This invention provides methods of using cell free bodily fluid and blood cells in the diagnosis, prognosis, or monitoring of diseases or conditions. The invention also relates to methods of using cell free bodily fluid and blood cells to identify markers of diseases or conditions.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36700610P | 2010-07-23 | 2010-07-23 | |
PCT/US2011/044969 WO2012012693A2 (en) | 2010-07-23 | 2011-07-22 | Methods for detecting signatures of disease or conditions in bodily fluids |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013000916A MX2013000916A (en) | 2013-07-05 |
MX361944B true MX361944B (en) | 2018-12-19 |
Family
ID=45497477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013000916A MX361944B (en) | 2010-07-23 | 2011-07-22 | Methods for detecting signatures of disease or conditions in bodily fluids. |
Country Status (12)
Country | Link |
---|---|
US (5) | US20120053073A1 (en) |
EP (2) | EP4303584A3 (en) |
JP (5) | JP2013538565A (en) |
KR (1) | KR20130041961A (en) |
CN (2) | CN103119179A (en) |
AU (2) | AU2011280996B2 (en) |
BR (1) | BR112013001754A2 (en) |
CA (1) | CA2806291C (en) |
EA (1) | EA201390150A1 (en) |
MX (1) | MX361944B (en) |
SG (2) | SG10201505723UA (en) |
WO (1) | WO2012012693A2 (en) |
Families Citing this family (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG10201704689XA (en) | 2008-01-18 | 2017-07-28 | Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
AU2011280997A1 (en) | 2010-07-23 | 2013-02-28 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
US20130203624A1 (en) | 2010-07-23 | 2013-08-08 | President And Fellows Of Harvard College | Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions |
KR101212714B1 (en) * | 2011-01-26 | 2013-01-22 | 계명대학교 산학협력단 | Clinical diagnosis support method based on hierarchical fuzzy inference technology, and system |
WO2013113012A2 (en) | 2012-01-27 | 2013-08-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for profiling and quantitating cell-free rna |
US9220733B2 (en) | 2012-03-19 | 2015-12-29 | The Regents Of The University Of California | Solubilization of antigen components for removal from tissues |
WO2013162458A1 (en) * | 2012-04-24 | 2013-10-31 | Wahren Herlenius Marie | Ro52 AS A PREDICTIVE MARKER FOR IMMUNE DERIVED TUMOR OUTCOME |
WO2013173642A1 (en) * | 2012-05-18 | 2013-11-21 | Sanford-Burnham Medical Research Institute | High-throughput lipidomics |
KR20150035821A (en) * | 2012-06-15 | 2015-04-07 | 해리 스타일리 | Methods of detecting diseases or conditions |
KR20150035818A (en) * | 2012-06-15 | 2015-04-07 | 해리 스타일리 | Methods of detecting diseases or conditions using circulating diseased cells |
US10876152B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US11913065B2 (en) | 2012-09-04 | 2024-02-27 | Guardent Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
IL269097B2 (en) | 2012-09-04 | 2024-01-01 | Guardant Health Inc | Systems and methods to detect rare mutations and copy number variation |
US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
NZ706269A (en) * | 2012-09-20 | 2016-08-26 | Univ Hong Kong Chinese | Non-invasive determination of methylome of fetus or tumor from plasma |
US9732390B2 (en) | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
US10706957B2 (en) | 2012-09-20 | 2020-07-07 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of tumor from plasma |
CN105025878A (en) * | 2012-10-03 | 2015-11-04 | 外来体诊断公司 | Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions |
CN102912029A (en) * | 2012-11-06 | 2013-02-06 | 俞杨 | Method for detecting single nucleotide polymorphism at site CISH+1320 of human tubercle bacillus related susceptibility gene |
GB201220573D0 (en) | 2012-11-15 | 2013-01-02 | Univ Central Lancashire | Methods of diagnosing proliferative disorders |
GB201302837D0 (en) * | 2013-02-19 | 2013-04-03 | Univ Singapore | Therapeutic Agents |
US11585814B2 (en) | 2013-03-09 | 2023-02-21 | Immunis.Ai, Inc. | Methods of detecting prostate cancer |
US10494675B2 (en) | 2013-03-09 | 2019-12-03 | Cell Mdx, Llc | Methods of detecting cancer |
ES2859645T3 (en) | 2013-03-14 | 2021-10-04 | Mayo Found Medical Education & Res | Neoplasia detection |
US10119978B2 (en) * | 2013-03-15 | 2018-11-06 | Wallac Oy | System and method for determining risk of diabetes based on biochemical marker analysis |
CN107941681B (en) * | 2013-04-19 | 2021-07-30 | 艾皮恩蒂斯有限公司 | Method for identifying quantitative cellular composition in biological sample |
CN103293321B (en) * | 2013-05-27 | 2015-05-13 | 北京大学 | Kit for detecting DNA (Deoxyribose Nucleic Acid) damage induced early-stage nucleolus stress and application of kit |
CN103555818A (en) * | 2013-07-16 | 2014-02-05 | 中国人民解放军海军医学研究所 | Application of B cell translocation gene 2 as low dose ionizing radiation biological dosimeter |
US10428383B2 (en) * | 2013-07-24 | 2019-10-01 | The Chinese University Of Hong Kong | Biomarkers for premature birth and use thereof |
CN104374853A (en) * | 2013-08-14 | 2015-02-25 | 柯跃斌 | Method for high performance liquid chromatography(HPLC)-mass spectrometry (MS) detection of DNA oxidation and DNA methylation |
WO2015081110A2 (en) * | 2013-11-27 | 2015-06-04 | William Beaumont Hospital | Method for predicting congenital heart defect |
WO2015095359A1 (en) * | 2013-12-17 | 2015-06-25 | Harry Stylli | Methods of detecting diseases or conditions |
CA2934822A1 (en) | 2013-12-28 | 2015-07-02 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
KR102001554B1 (en) * | 2014-01-16 | 2019-07-18 | 일루미나, 인코포레이티드 | Amplicon preparation and sequencing on solid supports |
JP5897228B2 (en) * | 2014-02-28 | 2016-03-30 | 国立研究開発法人国立がん研究センター | Prognosis method for renal cell carcinoma |
EP4234722A3 (en) | 2014-03-31 | 2023-09-20 | Mayo Foundation for Medical Education and Research | Detecting colorectal neoplasm |
EP3140421B8 (en) | 2014-05-09 | 2020-05-06 | Eurofins LifeCodexx GmbH | Detection of dna that originates from a specific cell-type and related methods |
EP2942400A1 (en) | 2014-05-09 | 2015-11-11 | Lifecodexx AG | Multiplex detection of DNA that originates from a specific cell-type |
JP2017518514A (en) * | 2014-05-16 | 2017-07-06 | インターミューン, インコーポレイテッド | LPA-related protein and RNA expression |
CN104101715A (en) * | 2014-07-15 | 2014-10-15 | 重庆医科大学附属儿童医院 | Kit for detecting DOCK8 (dedicator of cytokinesis 8) protein and non-diagnostic DOCK8 protein detection method |
WO2016040843A1 (en) * | 2014-09-11 | 2016-03-17 | Harry Stylli | Methods of detecting prostate cancer |
CN104357559A (en) * | 2014-10-27 | 2015-02-18 | 同济大学 | Identification method for key ribosomal proteins in developmental regulation of female schistosoma japonicum katsurada |
CN104280478B (en) * | 2014-11-03 | 2016-03-30 | 天津中医药大学 | Endogenous small-molecule substance is detecting the application in renal toxicity fast |
ES2790823T3 (en) | 2014-11-14 | 2020-10-29 | Liquid Genomics Inc | Use of circulating cell-free RNA for cancer diagnosis and / or monitoring |
WO2016095093A1 (en) * | 2014-12-15 | 2016-06-23 | 天津华大基因科技有限公司 | Method for screening tumor, method and device for detecting variation of target region |
US10030272B2 (en) | 2015-02-27 | 2018-07-24 | Mayo Foundation For Medical Education And Research | Detecting gastrointestinal neoplasms |
EP3316159A4 (en) | 2015-06-25 | 2019-08-14 | Advanced Telecommunications Research Institute International | Prediction device based on multiple organ-related system and prediction program |
CA2992790A1 (en) | 2015-08-31 | 2017-03-09 | Mayo Foundation For Medical Education And Research | Detecting gastric neoplasm |
JP6960924B2 (en) * | 2015-09-17 | 2021-11-05 | コンセホ・スペリオル・デ・インベスティガシオネス・シエンティフィカス(セエセイセ)Consejo Superior De Investigaciones Cientificas(Csic) | Methods for detecting circulating cells in superficial body fluids |
US20170097355A1 (en) * | 2015-10-06 | 2017-04-06 | University Of Washington | Biomarkers and methods to distinguish ovarian cancer from benign tumors |
HUE050491T2 (en) | 2015-11-10 | 2020-12-28 | Eurofins Lifecodexx Gmbh | Detection of foetal chromosomal aneuploidies using dna regions that are differentially methylated between the foetus and the pregnant female |
US10184932B2 (en) * | 2015-12-07 | 2019-01-22 | Zora Biosciences Oy | Use of ceramides and LPLs in diagnosing CVD |
SG11201805119QA (en) | 2015-12-17 | 2018-07-30 | Guardant Health Inc | Methods to determine tumor gene copy number by analysis of cell-free dna |
CN105506083B (en) * | 2015-12-24 | 2018-10-19 | 孙梅芬 | CAPG is preparing the purposes in diagnosing parkinsonism product |
CN205301177U (en) * | 2015-12-31 | 2016-06-08 | 深圳市贝沃德克生物技术研究院有限公司 | Domestic pneumonia mycoplasma infects detecting system |
JP7015171B2 (en) * | 2016-01-15 | 2022-02-02 | 公益財団法人がん研究会 | New fusion and its detection method |
CN116640847A (en) | 2016-02-02 | 2023-08-25 | 夸登特健康公司 | Cancer evolution detection and diagnosis |
CN105842037B (en) * | 2016-03-21 | 2018-07-31 | 山东农业大学 | Colouring method that is a kind of while showing mast cell and acidophic cell |
EP3466446B1 (en) | 2016-03-29 | 2023-12-27 | Karydo Therapeutix, Inc. | Pharmaceutical composition or food composition, and method for assessing effect of active ingredient in vivo |
US10370726B2 (en) | 2016-04-14 | 2019-08-06 | Mayo Foundation For Medical Education And Research | Detecting colorectal neoplasia |
CN105784873B (en) * | 2016-05-06 | 2017-10-13 | 常熟市医学检验所 | High lithemia injury of kidney early diagnosis marker and its application based on metabolism group |
EP3464645A4 (en) * | 2016-06-07 | 2020-05-06 | The Board of Trustees of the Leland Stanford Junior University | Methods for diagnosis of bacterial and viral infections |
CN107144620A (en) * | 2017-03-31 | 2017-09-08 | 兰州百源基因技术有限公司 | Diabetic nephropathy detects mark |
US11899020B2 (en) | 2017-03-31 | 2024-02-13 | The Regents Of The University Of California | Shotgun proteomic antigen identification |
CN107328746B (en) * | 2017-06-14 | 2020-01-31 | 宁波大学 | Preparation and application of multifunctional fluorescent biosensor based on nucleic acid-like coordination polymer |
US20200141948A1 (en) * | 2017-06-21 | 2020-05-07 | Korea Research Institute Of Bioscience And Biotechnology | Method and kit for diagnosis of muscle weakness-related diseases using blood biomarker |
WO2019018545A1 (en) | 2017-07-18 | 2019-01-24 | The Research Foundation For The State University Of New York | Biomarkers for intracranial aneurysm |
SG11202000444PA (en) * | 2017-08-04 | 2020-02-27 | Billiontoone Inc | Sequencing output determination and analysis with target-associated molecules in quantification associated with biological targets |
WO2019030311A1 (en) * | 2017-08-09 | 2019-02-14 | Pamgene Bv | Method for predicting the response of non-small-cell lung carcinoma patients to a medicament |
BR112020010343A2 (en) | 2017-11-23 | 2020-11-10 | Biosearch, S.A. | method to increase embryo implantation rate in a female patient suffering from polycystic ovary syndrome |
CN109658980B (en) * | 2018-03-20 | 2023-05-09 | 上海交通大学医学院附属瑞金医院 | Screening and application of fecal gene markers |
KR102072504B1 (en) * | 2018-05-23 | 2020-02-03 | 중앙대학교 산학협력단 | Composition and method for diagnosing atopic dermatitis using DOCK8 SNP |
EP3802624A4 (en) * | 2018-06-01 | 2022-03-23 | Musc Foundation for Research Development | Glycan analysis of proteins and cells |
CN108841928B (en) * | 2018-06-11 | 2021-11-23 | 河北医科大学 | Human mitochondrial genome methylation detection kit and application thereof |
WO2019241716A1 (en) * | 2018-06-14 | 2019-12-19 | Metabolomycs, Inc. | Metabolomic signatures for predicting, diagnosing, and prognosing various diseases including cancer |
CN108796067B (en) * | 2018-07-03 | 2019-10-25 | 北京泱深生物信息技术有限公司 | The diagnosis new function of MAEA gene in blood |
CN109266734A (en) * | 2018-09-25 | 2019-01-25 | 深圳市人民医院 | Autoimmune disease diagnostic kit and application |
CN109295230A (en) * | 2018-10-24 | 2019-02-01 | 福建翊善生物科技有限公司 | A method of the polygene combined abrupt climatic change based on ctDNA assesses tumour dynamic change |
MX2021009726A (en) | 2019-02-14 | 2021-09-14 | Mirvie Inc | Methods and systems for determining a pregnancy-related state of a subject. |
EP3936624A4 (en) * | 2019-03-08 | 2022-11-23 | Neogentc Corp. | Marker for predicting tumor reactivity of lymphocytes, and use thereof |
CN109821029B (en) * | 2019-04-08 | 2020-12-15 | 浙江大学 | Application of ZDHHC21 gene in preparing leukemia induced differentiation therapeutic medicine |
KR102169901B1 (en) * | 2019-05-17 | 2020-10-26 | 연세대학교 산학협력단 | Methods for providing information about responses to cancer immunotherapy using dna methylation and kits using the same |
WO2020243589A1 (en) * | 2019-05-29 | 2020-12-03 | Washington University | Methods of detecting clostridium difficile infections |
WO2021041931A1 (en) * | 2019-08-28 | 2021-03-04 | The Regents Of The University Of California | Methods of producing dna methylation profiles |
CN110514847B (en) * | 2019-09-24 | 2022-06-10 | 北京市心肺血管疾病研究所 | Application of serum LysoPA in children dilated cardiomyopathy prognosis |
CN112697889B (en) * | 2019-10-22 | 2022-03-08 | 中国科学院大连化学物理研究所 | Application of serum metabolism marker and detection kit |
CN111189683A (en) * | 2020-01-06 | 2020-05-22 | 中国科学院地质与地球物理研究所 | Preparation method of ion probe liquid sample target |
CN111341448B (en) * | 2020-03-03 | 2023-12-19 | 西安交通大学 | Method for predicting complex diseases and phenotype-associated metabolites based on Mendelian randomization |
CN111041089B (en) * | 2020-03-13 | 2020-06-19 | 广州微远基因科技有限公司 | Application of host marker for COVID-19 infection |
US20230168257A1 (en) * | 2020-04-01 | 2023-06-01 | Aska Pharmaceutical Co., Ltd. | Methods for differentiating destructive thyroiditis from other pathological conditions |
CN111334572B (en) * | 2020-04-26 | 2020-10-27 | 江苏大学附属医院 | New application of CTSZ gene methylation |
CN112305220B (en) * | 2020-06-03 | 2021-07-23 | 四川大学华西第二医院 | Application of cathepsin Z in early warning and diagnosis of preeclampsia and product |
CN111679018B (en) * | 2020-08-14 | 2020-11-20 | 宝枫生物科技(北京)有限公司 | Biomarkers for diagnosing cognitive disorders and uses thereof |
CN112305118B (en) * | 2020-10-30 | 2022-03-22 | 河北医科大学第二医院 | L-octanoyl carnitine as biomarker for disease diagnosis |
CN112501175A (en) * | 2020-12-14 | 2021-03-16 | 南通大学 | Psoriasis inhibiting gene and application thereof |
US11152103B1 (en) | 2020-12-29 | 2021-10-19 | Kpn Innovations, Llc. | Systems and methods for generating an alimentary plan for managing musculoskeletal system disorders |
CN113295874B (en) * | 2021-05-25 | 2022-03-04 | 广东源心再生医学有限公司 | Novel marker for auxiliary diagnosis of valvular heart disease and auxiliary diagnosis product |
CN113267394A (en) * | 2021-06-10 | 2021-08-17 | 谱天(天津)生物科技有限公司 | FFPE reference substance for proteome quality control, and preparation method and application thereof |
CN113252910B (en) * | 2021-06-29 | 2022-05-17 | 中国人民解放军军事科学院军事医学研究院 | Application of TIMP3 in anxiety and depression diagnosis |
CA3225337A1 (en) * | 2021-07-09 | 2023-01-12 | Brent WINSTON | Metabolomic profiles for prediction of functional neurological outcome or death following severe traumatic brain injury |
WO2023044118A1 (en) * | 2021-09-20 | 2023-03-23 | Droplet Biosciences, Inc. | Methods for disease assessment using drain fluid |
WO2023250229A1 (en) * | 2022-06-23 | 2023-12-28 | Oklahoma Medical Research Foundation | Autoantibody biomarkers of ro/ss-a antibody negative sjogren's syndrome/sjogren's disease |
CN115575646B (en) * | 2022-11-21 | 2023-04-28 | 四川大学华西医院 | Application of metabolic marker group in preparation of kit for predicting epileptic seizure |
Family Cites Families (229)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4868103A (en) | 1986-02-19 | 1989-09-19 | Enzo Biochem, Inc. | Analyte detection by means of energy transfer |
US4843155A (en) | 1987-11-19 | 1989-06-27 | Piotr Chomczynski | Product and process for isolating RNA |
US5459039A (en) | 1989-05-12 | 1995-10-17 | Duke University | Methods for mapping genetic mutations |
EP0552108B1 (en) | 1992-01-17 | 1999-11-10 | Lakowicz, Joseph R. | Energy transfer phase-modulation fluoro-immunoassay |
DE69433811T2 (en) | 1993-01-07 | 2005-06-23 | Sequenom, Inc., San Diego | DNA SEQUENCING BY MASS SPECTROMONY |
GB2291059B (en) | 1993-03-19 | 1997-09-24 | North Sydney Area Health Serv | Papp-a,its immunodetection and uses |
US5594637A (en) | 1993-05-26 | 1997-01-14 | Base Ten Systems, Inc. | System and method for assessing medical risk |
US5498531A (en) | 1993-09-10 | 1996-03-12 | President And Fellows Of Harvard College | Intron-mediated recombinant techniques and reagents |
US5514598A (en) | 1993-11-30 | 1996-05-07 | Doody; Michael | Prenatal detection of meconium |
US6025395A (en) | 1994-04-15 | 2000-02-15 | Duke University | Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders |
US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
US6031088A (en) | 1996-05-23 | 2000-02-29 | Albert Einstein College Of Medicine Of Yeshiva University | Polycystic kidney disease PKD2 gene and uses thereof |
US20010051341A1 (en) | 1997-03-04 | 2001-12-13 | Isis Innovation Limited | Non-invasive prenatal diagnosis |
GB9704444D0 (en) | 1997-03-04 | 1997-04-23 | Isis Innovation | Non-invasive prenatal diagnosis |
US20020119118A1 (en) | 1997-11-03 | 2002-08-29 | Genentech, Inc. | Novel polypeptides and nucleic acids encoding bolekine |
CA2359816C (en) | 1999-01-06 | 2010-08-03 | Genenews Inc. | Method for the detection of gene transcripts in blood and uses thereof |
AU2005200170A1 (en) * | 1999-03-05 | 2005-02-10 | University Of Iowa Research Foundation | Diagnostics and therapeutics for drusen associated ocular disorders |
US6762032B1 (en) | 1999-08-23 | 2004-07-13 | Biocrystal, Ltd. | Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response |
AU2001275346A1 (en) | 2000-06-05 | 2001-12-17 | General Hospital Corporation | Compositions, kits, and methods for identification and modulation of type i diabetes |
ES2291246T3 (en) | 2000-06-27 | 2008-03-01 | Von Recklinghausen Gesellschaft E.V. | PROCEDURE FOR PURCHASING DATA FOR THE PRESINTOMATIC OR PRENATAL DIAGNOSIS OF NEUROPHRIBROMATOSIS OF TYPE 1. |
US6664056B2 (en) | 2000-10-17 | 2003-12-16 | The Chinese University Of Hong Kong | Non-invasive prenatal monitoring |
FR2816411B1 (en) | 2000-11-03 | 2003-07-04 | Inst Nat Sante Rech Med | MEANS FOR DETECTING THE PATHOLOGICAL TRANSFORMATION OF THE APP PROTEIN AND THEIR APPLICATIONS |
WO2002061434A2 (en) * | 2001-01-29 | 2002-08-08 | The Center For Blood Research, Inc | Anergy-regulated molecules |
US6753137B2 (en) | 2001-01-31 | 2004-06-22 | The Chinese University Of Hong Kong | Circulating epstein-barr virus DNA in the serum of patients with gastric carcinoma |
GB0104690D0 (en) | 2001-02-26 | 2001-04-11 | Cytogenetic Dna Services Ltd | Diagnostic test |
FR2824144B1 (en) | 2001-04-30 | 2004-09-17 | Metagenex S A R L | METHOD OF PRENATAL DIAGNOSIS ON FETAL CELLS ISOLATED FROM MATERNAL BLOOD |
CA2446666A1 (en) | 2001-05-09 | 2002-11-14 | Biovision Ag | Method for detecting progredient chronic dementia, and associated peptides and detection reagents |
WO2003019193A1 (en) | 2001-08-30 | 2003-03-06 | Ciphergen Biosystems, Inc. | Method of diagnosing nephrotic syndrome |
US6927028B2 (en) | 2001-08-31 | 2005-08-09 | Chinese University Of Hong Kong | Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA |
US7744876B2 (en) | 2002-04-09 | 2010-06-29 | The Curators Of The University Of Missouri | Methods and compositions for treatment, prevention, suppression, and/or delaying the onset of type 1 diabetes |
US7009038B2 (en) | 2002-05-02 | 2006-03-07 | Univ. Of Medicine & Dentistry Of N.J. | pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof |
CN102533972B (en) | 2002-05-09 | 2014-07-02 | 布赖汉姆妇女医院 | IL1RL-1 as a cardiovascular disease marker and therapeutic target |
US20040009518A1 (en) | 2002-05-14 | 2004-01-15 | The Chinese University Of Hong Kong | Methods for evaluating a disease condition by nucleic acid detection and fractionation |
US7157235B2 (en) | 2002-06-17 | 2007-01-02 | St. Vincent's Hospital Sydney Limited | Methods of diagnosis, prognosis and treatment of cardiovascular disease |
EP1520172A1 (en) | 2002-07-05 | 2005-04-06 | EVOTEC Neurosciences GmbH | Diagnostic and therapeutic use of tb2 gene and protein for neurodegenerative diseases |
FR2844279A1 (en) | 2002-09-06 | 2004-03-12 | Inst Nat Sante Rech Med | MEANS FOR DETECTING NEURODEGENERATIVE PROCESSES AND THEIR APPLICATIONS |
WO2004024098A2 (en) | 2002-09-16 | 2004-03-25 | Abgenix, Inc. | Method for the treatment of nephritis using anti-pdgf-dd antibodies |
CA2500652A1 (en) | 2002-10-02 | 2004-04-15 | Dmi Biosciences, Inc. | Diagnosis and monitoring of diseases |
US20040086864A1 (en) | 2002-10-22 | 2004-05-06 | The Chinese University Of Hong Kong | Novel classification methods for pleural effusions |
GB0225360D0 (en) | 2002-10-31 | 2002-12-11 | Univ London | Genetic markers |
AU2002952993A0 (en) | 2002-11-29 | 2002-12-12 | The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland | Therapeutic and diagnostic agents |
CA2513292C (en) | 2003-01-17 | 2016-04-05 | The Chinese University Of Hong Kong | Circulating mrna as diagnostic markers for pregnancy-related disorders |
EP1590673B1 (en) | 2003-02-04 | 2009-04-15 | EVOTEC Neurosciences GmbH | Diagnostic use of scn2b for alzheimer's disease |
US20080107600A1 (en) | 2003-02-13 | 2008-05-08 | Taiichi Katayama | Gene Marker And Composition For Diagnosis And Treatment Of Neurological Disorders And Diseases And Use Of The Same |
US20040191818A1 (en) | 2003-02-26 | 2004-09-30 | O'toole Margot Mary | Compositions and methods for diagnosing and treating autoimmune diseases |
WO2005094200A2 (en) | 2003-06-20 | 2005-10-13 | University Of Florida | Biomarkers for differentiating between type 2 and type 2 diabetes |
DE10333406A1 (en) | 2003-07-15 | 2005-02-10 | Protagen Ag | T-regulatory cells containing galectins for the therapy and diagnosis of diseases |
WO2005012907A1 (en) | 2003-08-01 | 2005-02-10 | Renovar, Inc. | Systems and methods for characterizing kidney diseases |
AU2004270220B2 (en) | 2003-09-05 | 2009-03-05 | The Chinese University Of Hong Kong | Method for non-invasive prenatal diagnosis |
US7445886B2 (en) | 2003-09-10 | 2008-11-04 | Board Of Regents, The University Of Texas System | Macrophage migration inhibitory factor as a marker for cardiovascular risk |
AU2004278782A1 (en) | 2003-10-03 | 2005-04-14 | Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services | Use of Cripto-1 as a biomarker for neurodegenerative disease and method of inhibiting progression thereof |
WO2005035725A2 (en) | 2003-10-08 | 2005-04-21 | The Trustees Of Boston University | Methods for prenatal diagnosis of chromosomal abnormalities |
DE60328193D1 (en) | 2003-10-16 | 2009-08-13 | Sequenom Inc | Non-invasive detection of fetal genetic traits |
WO2005050222A1 (en) | 2003-11-19 | 2005-06-02 | Evotec Neurosciences Gmbh | Diagnostic and therapeutic use of the human sgpl1 gene and protein for neurodegenerative diseases |
JP2007513337A (en) | 2003-11-19 | 2007-05-24 | サトリス, インコーポレイテッド | Diagnostic, stratified and monitoring methods for Alzheimer's disease |
US20060094064A1 (en) | 2003-11-19 | 2006-05-04 | Sandip Ray | Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids |
WO2005072340A2 (en) | 2004-01-27 | 2005-08-11 | Compugen Ltd. | Novel polynucleotides encoding polypeptides and methods using same |
EP1711633A1 (en) | 2004-02-04 | 2006-10-18 | EVOTEC Neurosciences GmbH | Diagnostic and therapeutic use of the kcne4 gene and protein for alzheimer disease |
WO2005082110A2 (en) | 2004-02-26 | 2005-09-09 | Illumina Inc. | Haplotype markers for diagnosing susceptibility to immunological conditions |
US8071552B2 (en) | 2004-04-05 | 2011-12-06 | Universite Bordeaux 2 | Peptides and peptidomimetics binding to CD23 |
US20080051334A1 (en) | 2004-04-16 | 2008-02-28 | Evotec Neurosciences Gmbh | Diagnostic and Therapeutic Use of Kcnc1 for Neurodegenerative Diseases |
US7838245B2 (en) | 2004-04-20 | 2010-11-23 | Sphingotec Gmbh | Use of precursors of tachykinins and/or their fragments in medical diagnostic |
US20090041862A1 (en) | 2004-05-07 | 2009-02-12 | Peter Robert Schofield | Detecting disease association with aberrant glycogen synthase kinase 3beta expression |
JP2007535959A (en) | 2004-05-10 | 2007-12-13 | エボテツク・ニユーロサイエンシーズ・ゲー・エム・ベー・ハー | Diagnostic and therapeutic use of KCNJ6 for Alzheimer's disease |
DE602005026931D1 (en) | 2004-05-13 | 2011-04-28 | Brahms Gmbh | USE OF PREPARATIONS OF ENKEPHALINES AND / OR THEIR FRAGMENTS IN MEDICAL DIAGNOSTICS |
US7678544B2 (en) | 2004-05-19 | 2010-03-16 | Statens Serum Institut | ADAM12, a novel marker for abnormal cell function |
US7709194B2 (en) | 2004-06-04 | 2010-05-04 | The Chinese University Of Hong Kong | Marker for prenatal diagnosis and monitoring |
CN101137903A (en) | 2004-07-19 | 2008-03-05 | 罗彻斯特大学 | Biomarkers of neurodegenerative disease |
US20060024757A1 (en) | 2004-07-30 | 2006-02-02 | Robert Hussa | Detection of oncofetal fibronectin for selection of concepti |
EP1789798A4 (en) | 2004-08-13 | 2009-02-18 | Xceed Molecular Corp | Markers for autoimmune disease detection |
US20070087376A1 (en) | 2004-08-30 | 2007-04-19 | Potashkin Judith A | Splice variants of pre-mRNA transcripts as biomarkers in idiopathic neurodegenerative diseases |
WO2006032126A1 (en) | 2004-09-24 | 2006-03-30 | Syn X Pharma, Inc. | Diagnosis and treatment of early pre-type-1 diabetes utilizing neuronal proteins |
WO2006050475A2 (en) | 2004-11-03 | 2006-05-11 | Brigham And Women's Hospital, Inc. | Identification of dysregulated genes in patients with neurological diseases |
WO2006048778A1 (en) | 2004-11-08 | 2006-05-11 | King's College London | Markers of predisposition to addictive states |
US20060115854A1 (en) | 2004-12-01 | 2006-06-01 | Power3 Medical Products, Inc. | Acetyl-LDL receptor related proteins and peptides as a biomarker for neurodegenerative disease |
US20060115855A1 (en) | 2004-12-01 | 2006-06-01 | Power3 Medical Products, Inc. | FK506-binding protein 7 related protein as a biomarker for neurodegenerative disease |
CA2590781A1 (en) | 2004-12-07 | 2006-06-15 | Electrophoretics Limited | Diagnosis of neurodegenerative diseases |
GB0426859D0 (en) | 2004-12-07 | 2005-01-12 | Proteome Sciences Plc | Diagnosis of neurodegenerative disorders |
AU2005323025A1 (en) | 2004-12-31 | 2006-07-13 | Biogen Idec Ma Inc. | Polypeptides that bind BR3 and uses thereof |
FR2880897B1 (en) | 2005-01-18 | 2010-12-17 | Inst Nat Sante Rech Med | METHOD OF DETECTION, NON-INVASIVE, PRENATAL, IN VITRO OF NORMAL HEALTHY CONDITION, HEALTHY CARRIER STATUS OR SICK CARRIER STATUS OF MUCOVISCIDOSIS |
US7432107B2 (en) | 2005-01-24 | 2008-10-07 | Roche Diagnostics Operations, Inc. | Cardiac hormones for assessing cardiovascular risk |
US7572592B2 (en) | 2005-01-31 | 2009-08-11 | Glycominds Ltd | Method for diagnosing multiple sclerosis |
US20070141625A1 (en) | 2005-02-03 | 2007-06-21 | Santos Jose H | Method for assessing risk of and predisposition to development of a pathology related to the presence of anti-epcr autoantibodies |
EP1859051A4 (en) | 2005-03-18 | 2009-08-05 | Univ Hong Kong Chinese | Markers for prenatal diagnosis and monitoring |
AU2006224971B2 (en) | 2005-03-18 | 2009-07-02 | Boston University | A method for the detection of chromosomal aneuploidies |
AU2006226891A1 (en) | 2005-03-24 | 2006-09-28 | Beth Israel Deaconess Medical Center | Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy |
DE602006014379D1 (en) | 2005-04-06 | 2010-07-01 | Klinik Und Poliklinik Fuer Psy | NEURODEGENERATIVE MARKERS FOR DEPRESSION. |
CN101198622A (en) | 2005-04-18 | 2008-06-11 | 都柏林伊丽莎白女皇神学院 | Polypeptides and use thereof |
WO2006114661A1 (en) | 2005-04-26 | 2006-11-02 | Dwek Raymond A | High throughput glycan analysis for diagnosing and monitoring rheumatoid arthritis and other autoimmune diseases |
JP5421590B2 (en) | 2005-05-18 | 2014-02-19 | ノバルティス アーゲー | Methods for diagnosis and treatment of diseases with autoimmune and / or inflammatory components |
GB0512401D0 (en) | 2005-06-17 | 2005-07-27 | Randox Lab Ltd | Method |
GB2428240A (en) | 2005-07-14 | 2007-01-24 | Univ Gen Ve | Diagnostic method for brain damage-related disorders |
US20070148661A1 (en) | 2005-07-19 | 2007-06-28 | Duke University | LSAMP Gene Associated With Cardiovascular Disease |
IL172297A (en) | 2005-10-03 | 2016-03-31 | Compugen Ltd | Soluble vegfr-1 variants for diagnosis of preeclamsia |
US20070218469A1 (en) | 2005-10-03 | 2007-09-20 | Ruth Navon | Novel mutations in hexosaminidase A |
US20070218519A1 (en) | 2005-10-11 | 2007-09-20 | Tethys Bioscience, Inc. | Diabetes-associated markers and methods of use thereof |
US8652467B2 (en) | 2005-10-14 | 2014-02-18 | The Regents Of The University Of Michigan | Dek protein compositions and methods of using the same |
TW200726845A (en) | 2006-01-02 | 2007-07-16 | Nat Defense Medical Ct | Biomarker molecular of renal illness and detecting method for the same |
EP1808694A1 (en) | 2006-01-17 | 2007-07-18 | Universitätsklinikum Freiburg | Method for diagnosing polycystic kidney disease |
FR2896588B1 (en) | 2006-01-20 | 2016-08-19 | Univ D'angers | METHOD OF IN VITRO DIAGNOSIS OF AUTOIMMUNE IMMUNE RESPONSE BY DETECTION OF ANTIBODIES AGAINST ANTIGEN PENTRAXIN 3. |
WO2007090126A2 (en) | 2006-01-30 | 2007-08-09 | Invitrogen Corporation | Compositions and methods for detecting and quantifying toxic substances in disease states |
US7459280B2 (en) | 2006-02-27 | 2008-12-02 | Picobella, Llc | Methods for diagnosing and treating kidney cancer |
KR20080104350A (en) | 2006-02-28 | 2008-12-02 | 페노미넘 디스커버리스 인코포레이티드 | Methods for the diagnosis of dementia and other neurological disorders |
US7488584B2 (en) | 2006-03-24 | 2009-02-10 | Picobella | Methods for diagnosing and treating kidney and colorectal cancer |
US20070224638A1 (en) | 2006-03-27 | 2007-09-27 | Institut Pasteur | Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections |
GB0606776D0 (en) | 2006-04-03 | 2006-05-10 | Novartis Pharma Ag | Predictive biomarkers for chronic allograft nephropathy |
EP1847615A1 (en) | 2006-04-18 | 2007-10-24 | Genoscreen | Expression and polymorphism of the ornithine transcarbamylase (OTC) gene as markers for diagnosing Alzheimer's disease |
US7662578B2 (en) | 2006-04-21 | 2010-02-16 | Children's Hospital Medical Center | Method and kit for the early detection of impaired renal status |
ATE517341T1 (en) | 2006-04-27 | 2011-08-15 | Critical Care Diagnostics Inc | INTERLEUKIN-33 (IL-33) FOR THE DIAGNOSIS AND PREDICTION OF CARDIOVASCULAR DISEASES |
EP3059594A1 (en) | 2006-05-01 | 2016-08-24 | Critical Care Diagnostics, Inc. | Prognosis of cardiovascular disease |
US7901884B2 (en) | 2006-05-03 | 2011-03-08 | The Chinese University Of Hong Kong | Markers for prenatal diagnosis and monitoring |
US7754428B2 (en) | 2006-05-03 | 2010-07-13 | The Chinese University Of Hong Kong | Fetal methylation markers |
EP2020445B1 (en) | 2006-05-12 | 2013-01-02 | Keio University | Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease |
WO2007131345A1 (en) | 2006-05-12 | 2007-11-22 | The Hospital For Sick Children | Genetic risk factor in sod1 and sfrs15 in renal disease, diabetic cataract, cardiovascular disease and longevity |
EP2548578B1 (en) | 2006-05-17 | 2014-08-20 | The Ludwig Institute for Cancer Research | Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases |
WO2007139895A2 (en) | 2006-05-24 | 2007-12-06 | Cellumen, Inc. | Method for modeling a disease |
US20080038269A1 (en) | 2006-05-25 | 2008-02-14 | Mount Sinai Hospital | Methods for detecting and treating kidney disease |
DE102006027818A1 (en) | 2006-06-16 | 2007-12-20 | B.R.A.H.M.S. Aktiengesellschaft | In vitro multiparameter determination method for the diagnosis and early diagnosis of neurodegenerative diseases |
WO2008084331A2 (en) | 2006-06-21 | 2008-07-17 | Hopitaux Universitaires De Geneve | Biomarkers for renal disorders |
WO2008003826A1 (en) | 2006-07-07 | 2008-01-10 | Oy Jurilab Ltd | Novel genes and markers in essential arterial hypertension |
KR100856375B1 (en) | 2006-07-18 | 2008-09-04 | 김현기 | Marker for diagnosing Neurodegenerative diseases |
US7851172B2 (en) | 2006-07-25 | 2010-12-14 | University Of Kentucky Research Foundation | Biomarkers of mild cognitive impairment and alzheimer's disease |
US20080026378A1 (en) | 2006-07-28 | 2008-01-31 | Gian Franco Bottazzo | Prediction and prophylactic treatment of type 1 diabetes |
US20080113358A1 (en) | 2006-07-28 | 2008-05-15 | Ravi Kapur | Selection of cells using biomarkers |
ITTO20060614A1 (en) | 2006-08-21 | 2008-02-22 | Uni Degli Studi Del Piemonte | "DIFFERENTIAL DIAGNOSIS FOR THE SCLERODERMIA" |
WO2008028257A1 (en) | 2006-09-08 | 2008-03-13 | Garvan Institute Of Medical Research | Diagnostics and therapeutics of neurological disease |
US20090318392A1 (en) | 2006-09-14 | 2009-12-24 | Zora Biosciences Oy | Biofluid metabolite profiling as a tool for early prediction of autoimmunity and type 1 diabetes risk |
EP1905841A1 (en) | 2006-09-25 | 2008-04-02 | Max Delbrück Centrum für Molekulare Medizin (MDC) Berlin-Buch; | Trex1 as a marker for lupus erythematosus |
US20090318354A1 (en) | 2006-09-26 | 2009-12-24 | Proteosys Ag | Use of at least one isoform of progesterone receptor membrane component 1 (PGRMC1) |
CA2665365A1 (en) | 2006-10-05 | 2008-04-10 | Rhode Island Hospital | Compositions and methods for detecting and treating renal injury and inflammation |
WO2008043725A1 (en) | 2006-10-10 | 2008-04-17 | Novartis Ag | Biomarker in inflammatory disorders |
EP2081649A2 (en) | 2006-10-11 | 2009-07-29 | Novartis AG | Modulation of cd1b or cd1d expression in autoimmune disorders |
US8088584B2 (en) | 2006-10-16 | 2012-01-03 | Bayer Schering Pharma Aktiengesellschaft | LTBP2 as a biomarker and diagnostic target |
WO2008046511A1 (en) | 2006-10-16 | 2008-04-24 | Bayer Schering Pharma Aktiengesellschaft | Crtac as a biomarker, therapeutic and diagnostic target |
WO2008046510A1 (en) | 2006-10-16 | 2008-04-24 | Bayer Healthcare Ag | Fn1 as a biomarker, therapeutic and diagnostic target |
EP2087359A1 (en) | 2006-10-16 | 2009-08-12 | Bayer Schering Pharma AG | Prss23 as a biomarker, therapeutic and diagnostic target |
WO2008046160A1 (en) | 2006-10-20 | 2008-04-24 | Newcastle Innovation Limited | Assay for the detection of biomarkers associated with pregnancy related conditions |
EP2097094A4 (en) | 2006-11-01 | 2011-01-05 | George Mason Intellectual Prop | Biomarkers for neurological conditions |
WO2008064336A2 (en) | 2006-11-22 | 2008-05-29 | Inivitrogen Corporation | Autoimmune disease biomarkers |
US20100169988A1 (en) | 2006-12-06 | 2010-07-01 | Bernhard Kohli | Means and methods for isolating and determining novel targets for the treatment of neurodegenerative, neurological or neuropsychiatric disorders and compositions comprising the same |
IL180095A0 (en) | 2006-12-14 | 2007-05-15 | Ohad Birk | Method for antenatal estimation of down syndrome risk |
US8362224B2 (en) | 2006-12-19 | 2013-01-29 | The Trustees Of The University Of Pennsylvania | Screening for CD93 (C1qRp)-associated polymorphism(S) in the diagnosis, prevention and treatment of autoimmune diseases |
US8815519B2 (en) | 2006-12-22 | 2014-08-26 | Hvidovre Hospital | Method for predicting cancer and other diseases |
EP2155228B1 (en) | 2007-01-10 | 2014-04-02 | Purdue Research Foundation | Polypeptide inhibitors of hsp27 kinase and uses therefor |
WO2008085024A1 (en) | 2007-01-12 | 2008-07-17 | Erasmus University Medical Center Rotterdam | Identification and detection of peptides relating to specific disorders |
EP2115168A1 (en) | 2007-01-22 | 2009-11-11 | Medizinische Universität Innsbruck | Novel markers for chronic kidney disease |
AU2008213742A1 (en) | 2007-02-08 | 2008-08-14 | Powmri Limited | Method of diagnosing a neurodegenerative disease |
WO2008100596A2 (en) | 2007-02-15 | 2008-08-21 | Burnham Institute For Medical Research | Biomarkers of neurodegenerative disease |
CA2679581C (en) | 2007-02-21 | 2020-12-22 | Anna Helgadottir | Genetic susceptibility variants associated with arterial disease |
WO2008112772A2 (en) | 2007-03-14 | 2008-09-18 | Baylor Research Institute | Gene expression in peripheral blood mononuclear cells from children with diabetes |
WO2008118813A2 (en) | 2007-03-26 | 2008-10-02 | The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services | Schizophrenia-related isoform of kcnh2 and development of antipsychotic drugs |
EP1975252A1 (en) | 2007-03-29 | 2008-10-01 | INSERM (Institut National de la Santé et de la Recherche Medicale) | Methods for the prognosis or for the diagnosis of a thyroid disease |
JP5555846B2 (en) | 2007-03-30 | 2014-07-23 | 国立大学法人山口大学 | Prognosis determination method for acute central nervous system disorder |
CA2683865A1 (en) | 2007-04-12 | 2008-10-23 | Apitope International Nv | Biomarkers for multiple sclerosis |
GB0707933D0 (en) | 2007-04-24 | 2007-05-30 | Apitope Technology Bristol Ltd | Disease markers |
GB0708075D0 (en) | 2007-04-26 | 2007-06-06 | Univ Nottingham | Nethods |
EP2162459B1 (en) | 2007-05-01 | 2017-10-04 | University of Miami | Transcriptomic biomarkers for individual risk assessment in new onset heart failure |
CA2686861A1 (en) | 2007-05-03 | 2008-11-13 | Medimmune, Llc | Interferon alpha-induced pharmacodynamic markers |
WO2008147938A2 (en) | 2007-05-24 | 2008-12-04 | Centocor, Inc. | Wnt5a as an inflammatory disease marker |
WO2008154238A1 (en) | 2007-06-06 | 2008-12-18 | Siemens Healthcare Diagnostics Inc. | Predictive diagnostics for kidney disease |
US20090142792A1 (en) | 2007-06-21 | 2009-06-04 | Robinson William H | Biomarkers for the diagnosis of autoimmune disease |
ITRM20070351A1 (en) | 2007-06-22 | 2008-12-23 | Istituto Naz Per Le Malattie I | GENE CODIFYING AMBER PROTEIN 1 HAVING REGULATORY ACTIVITY OF THE SELF-FAILURE AND DEVELOPMENT OF THE CENTRAL NERVOUS SYSTEM |
WO2009000520A1 (en) | 2007-06-25 | 2008-12-31 | Universität Duisburg-Essen | Screening-method for polymorphic markers in htra1 gene in neurodegenerative disorders |
EP2167961A4 (en) | 2007-06-27 | 2010-07-21 | Univ Leland Stanford Junior | Beta2-microglobulin and c reactive protein (crp) as biomarkers for peripheral artery disease |
FR2918329B1 (en) | 2007-07-06 | 2009-10-02 | Renault Sas | COOLING ECOPE FOR MOTOR VEHICLE |
JP2010533866A (en) | 2007-07-13 | 2010-10-28 | ジェネンテック, インコーポレイテッド | Methods for treating and diagnosing cancer, inflammatory diseases and autoimmune diseases |
ES2443540T3 (en) | 2007-07-17 | 2014-02-19 | Metabolon, Inc. | Biomarkers for pre-diabetes and methods that use them |
EP2185936A4 (en) | 2007-08-02 | 2010-08-04 | Iss Immune System Stimulation | Diagnosis, staging and monitoring of inflammatory bowel disease |
WO2009032722A1 (en) | 2007-08-29 | 2009-03-12 | The Cleveland Clinic Foundation | Carbamylated proteins and risk of cardiovascular disease |
US20090275046A1 (en) | 2007-08-29 | 2009-11-05 | Power3 Medical Products, Inc. | Complement factor H protein as a biomarker of Parkinson's disease |
US8748100B2 (en) | 2007-08-30 | 2014-06-10 | The Chinese University Of Hong Kong | Methods and kits for selectively amplifying, detecting or quantifying target DNA with specific end sequences |
GB0717637D0 (en) | 2007-09-10 | 2007-10-17 | Univ Leiden | Future cardiac event biomarkers |
US8062852B2 (en) | 2007-10-01 | 2011-11-22 | The Children's Hospital And Regional Medical Center | Detection and treatment of autoimmune disorders |
ITUD20070183A1 (en) | 2007-10-01 | 2009-04-02 | Univ Degli Studi Udine | DIAGNOSTIC AND PROGNOSTIC METHOD FOR DIAGNOSIS AND PROGNOSIS OF LYMPHOPROLIFERATION IN AUTOIMMUNE DISEASES |
GB0720113D0 (en) * | 2007-10-15 | 2007-11-28 | Cambridge Cancer Diagnostics L | Diagnostic, prognostic and predictive testing for cancer |
EP2212693B1 (en) | 2007-10-22 | 2015-04-22 | The Regents of The University of California | Biomarkers for prenatal diagnosis of congenital cytomegalovirus |
FI20070795A0 (en) | 2007-10-24 | 2007-10-24 | Faron Pharmaceuticals Oy | A new biomarker for monitoring disease development and assessing the effectiveness of therapies |
EP2557425A3 (en) | 2007-10-26 | 2013-07-10 | Biohit Oyj | Methods and products for diagnosing autoimmune diseases and gastric cancer linked with atrophic gastritis |
WO2009059259A2 (en) | 2007-10-31 | 2009-05-07 | Children's Hospital Medical Center | Detection of worsening renal disease in subjects with systemic lupus erythematosus |
WO2009058168A1 (en) | 2007-11-04 | 2009-05-07 | Prediction Sciences Llc | Cellular fibronectin as a diagnostic marker in cardiovascular disease and methods of use thereof |
US20100233716A1 (en) | 2007-11-08 | 2010-09-16 | Pierre Saint-Mezard | Transplant rejection markers |
WO2009065132A1 (en) | 2007-11-16 | 2009-05-22 | Oklahoma Medical Research Foundation | Predicting and diagnosing patients with autoimmune disease |
US20100255485A1 (en) | 2007-11-28 | 2010-10-07 | Pico Caroni | Biomarkers for the onset of neurodegenerative diseases |
US8506933B2 (en) | 2007-11-30 | 2013-08-13 | Msdx, Inc. | Methods of detecting a neurological condition via analysis of circulating phagocytes |
WO2009074331A2 (en) | 2007-12-11 | 2009-06-18 | Julius-Maximilians-Universität Würzburg | Early and differential diagnosis test for alzheimer's disease |
WO2009075566A1 (en) | 2007-12-12 | 2009-06-18 | Erasmus University Medical Center Rotterdam | Biomarkers for cardiovascular disease |
EP2075343A1 (en) | 2007-12-21 | 2009-07-01 | Gert Mayer | A method of diagnosing a progressive disease |
EP2240601B1 (en) | 2007-12-27 | 2016-10-12 | Compugen Ltd. | Biomarkers for the prediction of renal injury |
SG10201704689XA (en) * | 2008-01-18 | 2017-07-28 | Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
CA2739944A1 (en) | 2008-01-23 | 2009-07-30 | Rigshospitalet | Classification of individuals suffering from cardiovascular diseases according to survival prognoses as found by measuring the levels of biomarker ykl-40 |
WO2009097450A1 (en) | 2008-01-30 | 2009-08-06 | Dexcom. Inc. | Continuous cardiac marker sensor system |
EP3115785A3 (en) | 2008-02-04 | 2017-02-22 | Banyan Biomarkers, Inc. | Process to diagnose or treat brain injury |
AU2009212216B2 (en) | 2008-02-08 | 2015-04-09 | Brigham And Women's Hospital, Inc. | Disease markers and uses thereof |
US20090239242A1 (en) | 2008-03-18 | 2009-09-24 | Biotrin Intellectual Properties Limited | Method for the early identification and prediction of kidney injury |
AU2008255192A1 (en) | 2008-03-22 | 2009-10-08 | Newcastle Innovation Limited | Detection of a biomarker of aberrant cells of neuroectodermal origin in a body fluid |
GB0809069D0 (en) | 2008-05-19 | 2008-06-25 | Univ Leuven Kath | Gene signatures |
EP2107377A1 (en) | 2008-04-04 | 2009-10-07 | BRAHMS Aktiengesellschaft | Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events |
WO2009122387A1 (en) | 2008-04-04 | 2009-10-08 | Biotrin Group Ltd. | Method for the detection and prediction of obesity-related renal disease |
AU2009237710A1 (en) | 2008-04-15 | 2009-10-22 | Rainer Oberbauer | Markers of acute kidney failure |
US8030097B2 (en) | 2008-04-30 | 2011-10-04 | Versitech Limited and R & C Biogenius Limited | Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks |
WO2010005750A2 (en) | 2008-06-16 | 2010-01-14 | The Regents Of The University Of California | Potential prognostic markers and therapeutic targets for neurological disorders |
US20100167937A1 (en) | 2008-07-08 | 2010-07-01 | Power3 Medical Products, Inc. | Multiple forms of Alzheimer's disease based on differences in concentrations of protein biomarkers in blood serum |
US20110177509A1 (en) | 2008-07-23 | 2011-07-21 | The Washington University | Risk factors and a therapeutic target for neurodegenerative disorders |
JP2011529453A (en) | 2008-07-31 | 2011-12-08 | ホスピタル クリニク アイ プロビンシアル デ バルセロナ | Healthy kidney biomarkers |
EP4235181A3 (en) | 2008-08-11 | 2024-02-28 | Banyan Biomarkers Inc | Biomarker detection process and assay of neurological condition |
ES2341419B1 (en) | 2008-08-14 | 2011-05-03 | Hospital Clinic I Provincial De Barcelona | WNT1 AS RENAL DAMAGE BIOMARCATOR. |
WO2010022210A2 (en) | 2008-08-21 | 2010-02-25 | Pxbiosciences Llc | Diagnosis and monitoring of renal failure using peptide biomarkers |
WO2010025434A1 (en) | 2008-08-29 | 2010-03-04 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
EP2161577A1 (en) * | 2008-09-01 | 2010-03-10 | Atlas Antibodies AB | ANLN protein |
CA2737379A1 (en) | 2008-09-30 | 2010-04-08 | Genentech, Inc. | Biological markers predictive of rheumatoid arthritis response to lymphotoxin antagonists |
US20100124756A1 (en) | 2008-10-10 | 2010-05-20 | Sandip Ray | Collection of biomarkers for diagnosis and monitoring of alzheimer's disease in body fluids |
GB0818650D0 (en) | 2008-10-10 | 2008-11-19 | Uni I Oslo | Methods |
WO2010048347A2 (en) | 2008-10-21 | 2010-04-29 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
NZ628843A (en) | 2008-10-21 | 2016-02-26 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
KR101051435B1 (en) * | 2008-10-22 | 2011-07-22 | 한국생명공학연구원 | Colorectal cancer diagnostic kit using colorectal cancer-related markers and colorectal cancer diagnostic method using the same |
EP2180322A1 (en) | 2008-10-22 | 2010-04-28 | BRAHMS Aktiengesellschaft | Prognostic biomarkers for the progression of primary chronic kidney disease |
WO2010048497A1 (en) | 2008-10-24 | 2010-04-29 | Genizon Biosciences Inc. | Genetic profile of the markers associated with alzheimer's disease |
WO2010046503A2 (en) | 2008-10-24 | 2010-04-29 | Vereniging Vu-Windesheim | Biomarkers for predicting the development of chronic autoimmune diseases |
US20110236397A1 (en) | 2008-11-06 | 2011-09-29 | University Of Miami | Limited proteolysis of cd2ap and progression of renal disease |
EP2719774B8 (en) | 2008-11-07 | 2020-04-22 | Adaptive Biotechnologies Corporation | Methods of monitoring conditions by sequence analysis |
BRPI0922021A2 (en) | 2008-11-10 | 2019-09-24 | Astute Medical Inc | method for assessing kidney condition in an individual, and use of one or more markers of kidney injury |
WO2010056757A1 (en) | 2008-11-11 | 2010-05-20 | Entelos, Inc. | Biomarkers for assessing atherosclerotic potential |
US20120094295A1 (en) | 2008-11-21 | 2012-04-19 | The Johns Hopkins University | Neurodegenerative disease diagnostic compositions and methods of use |
ES2528799T3 (en) | 2008-11-22 | 2015-02-12 | Astute Medical, Inc. | Methods for the prognosis of acute renal failure |
IT1392551B1 (en) | 2008-11-25 | 2012-03-09 | Bioindustry Park Del Canavese S P A | BIOMARCERS FOR DIAGNOSIS AND TO DETECT THE PROGRESSION OF NEURODEGENERATIVE DISEASES, IN PARTICULAR OF AMIOTROPHIC LATERAL SCLEROSIS |
AU2009326857B2 (en) | 2008-12-09 | 2016-05-26 | Stephanie Fryar-Williams | Novel biomarkers |
EP3474016A1 (en) | 2008-12-10 | 2019-04-24 | Joslin Diabetes Center, Inc. | Methods of diagnosing and predicting renal disease |
-
2011
- 2011-07-22 MX MX2013000916A patent/MX361944B/en active IP Right Grant
- 2011-07-22 EA EA201390150A patent/EA201390150A1/en unknown
- 2011-07-22 JP JP2013521843A patent/JP2013538565A/en active Pending
- 2011-07-22 CN CN2011800461731A patent/CN103119179A/en active Pending
- 2011-07-22 AU AU2011280996A patent/AU2011280996B2/en active Active
- 2011-07-22 CA CA2806291A patent/CA2806291C/en active Active
- 2011-07-22 SG SG10201505723UA patent/SG10201505723UA/en unknown
- 2011-07-22 WO PCT/US2011/044969 patent/WO2012012693A2/en active Application Filing
- 2011-07-22 BR BR112013001754A patent/BR112013001754A2/en not_active Application Discontinuation
- 2011-07-22 SG SG2013004791A patent/SG187159A1/en unknown
- 2011-07-22 EP EP23188166.5A patent/EP4303584A3/en active Pending
- 2011-07-22 CN CN201911204448.4A patent/CN110846405A/en active Pending
- 2011-07-22 US US13/188,683 patent/US20120053073A1/en not_active Abandoned
- 2011-07-22 KR KR1020137004461A patent/KR20130041961A/en not_active Application Discontinuation
- 2011-07-22 EP EP20110810446 patent/EP2596132A4/en not_active Ceased
-
2015
- 2015-03-20 US US14/664,176 patent/US20150299810A1/en not_active Abandoned
-
2016
- 2016-10-21 JP JP2016206825A patent/JP2017060479A/en active Pending
-
2017
- 2017-03-02 AU AU2017201440A patent/AU2017201440B2/en active Active
-
2018
- 2018-04-17 US US15/955,199 patent/US20190085402A1/en active Pending
- 2018-11-05 JP JP2018207960A patent/JP2019068804A/en not_active Withdrawn
-
2021
- 2021-02-05 JP JP2021017763A patent/JP2021074011A/en active Pending
-
2022
- 2022-04-08 US US17/716,329 patent/US20220298582A1/en active Pending
- 2022-04-08 US US17/716,335 patent/US20220298583A1/en active Pending
-
2023
- 2023-05-17 JP JP2023081918A patent/JP2023101574A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
SG187159A1 (en) | 2013-02-28 |
AU2011280996A1 (en) | 2013-02-28 |
MX2013000916A (en) | 2013-07-05 |
JP2013538565A (en) | 2013-10-17 |
JP2019068804A (en) | 2019-05-09 |
AU2017201440A1 (en) | 2017-03-16 |
CA2806291C (en) | 2023-08-29 |
EP4303584A2 (en) | 2024-01-10 |
EP4303584A3 (en) | 2024-04-03 |
US20220298582A1 (en) | 2022-09-22 |
BR112013001754A2 (en) | 2016-05-31 |
CA2806291A1 (en) | 2012-01-26 |
JP2023101574A (en) | 2023-07-21 |
US20150299810A1 (en) | 2015-10-22 |
US20220298583A1 (en) | 2022-09-22 |
JP2021074011A (en) | 2021-05-20 |
AU2011280996B2 (en) | 2017-03-30 |
EP2596132A4 (en) | 2013-12-18 |
JP2017060479A (en) | 2017-03-30 |
CN110846405A (en) | 2020-02-28 |
CN103119179A (en) | 2013-05-22 |
US20120053073A1 (en) | 2012-03-01 |
EA201390150A1 (en) | 2013-09-30 |
WO2012012693A2 (en) | 2012-01-26 |
AU2017201440B2 (en) | 2019-06-20 |
EP2596132A2 (en) | 2013-05-29 |
WO2012012693A3 (en) | 2012-06-14 |
SG10201505723UA (en) | 2015-09-29 |
KR20130041961A (en) | 2013-04-25 |
US20190085402A1 (en) | 2019-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX361944B (en) | Methods for detecting signatures of disease or conditions in bodily fluids. | |
BR112013001752A2 (en) | method of detecting disease or condition using phagocytic cells | |
GB201209668D0 (en) | Methods of monitoring conditions by sequence analysis | |
WO2012012704A3 (en) | Methods of detecting kidney-associated diseases or conditions | |
EA201590027A1 (en) | DETECTION METHODS OF DISEASES OR CONDITIONS | |
WO2013039477A8 (en) | Non-invasive methods of detecting target molecules | |
WO2012054638A3 (en) | Nmr systems and methods for the detection of analytes | |
WO2010017515A3 (en) | Breast cancer specific markers and methods of use | |
WO2009025852A3 (en) | Methods of using mirna for detection of in vivo cell death | |
NZ602007A (en) | Methods of detecting signatures of disease or conditions in bodily fluids | |
WO2012047899A3 (en) | Novel dna hypermethylation diagnostic biomarkers for colorectal cancer | |
MX2011012913A (en) | Methods for breast cancer risk assessment. | |
NZ605698A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
WO2011015602A3 (en) | Lung cancer biomarkers | |
WO2013066369A3 (en) | Methods for detecting graft-versus-host disease | |
WO2011015944A3 (en) | Use of free dna as an early predictor of severity in acute pancreatitis | |
EA201590024A1 (en) | METHODS FOR IDENTIFYING DISEASES OR CONDITIONS WITH THE APPLICATION OF CIRCULATING PATIOUS CELLS | |
MX2013000502A (en) | Methods and kits for the diagnosis of prostate cancer. | |
WO2014004889A3 (en) | Plasma analytes predict diagnosis and prognosis of thoracic aortic aneurysm | |
WO2017027391A3 (en) | Genetic abnormalities in plasma cell dyscrasias | |
NZ608316A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
WO2010088688A3 (en) | Diagnosis of in situ and invasive breast cancer | |
AU2010202926B2 (en) | Markers and methods relating to the assessment of Alzheimer's disease | |
WO2014087255A3 (en) | Systems and methods for monitoring biological fluids | |
WO2013101276A3 (en) | Diagnosis and detection of disease conditions modulated by activation of the sphingolipid pathway |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |